| Stacey J Rogers, MD | |
|
725 Volvo Pkwy, Suite 200, Chesapeake, VA 23320-1602 | |
| (757) 549-4403 | |
| (757) 549-4332 |
| Full Name | Stacey J Rogers |
|---|---|
| Gender | Female |
| Speciality | Gynecological Oncology |
| Experience | 31 Years |
| Location | 725 Volvo Pkwy, Chesapeake, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760487318 | NPI | - | NPPES |
| 010090989 | Medicaid | VA | |
| 75798 | Other | VA | OPTIMA |
| P00157173 | Other | VA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 0101235217 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chesapeake Regional Medical Center | Chesapeake, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Oncology Associates | 2769395797 | 101 |
News Archive
Scientists at Northwestern University report a surprising discovery that offers a possible new route for the treatment of neurodegenerative diseases. In a study of the transparent roundworm C. elegans, they found that a genetic switch in master neurons inhibits the proper functioning of protective cell stress responses, leading to the accumulation of misfolded and damaged proteins.
A new study at the Hebrew University of Jerusalem has found that Ethiopian women who immigrated to Israel gained significant amounts of weight, and some became obese, after integrating local foods into their diet and eating fewer traditional dishes.
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
The Bay Area Lyme Foundation today announced the first annual Bay Area Lyme Foundation 'Emerging Leader Award' and a $100,000 grant which will be given to a promising scientist who embodies the future of leadership in Lyme disease research.
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated with two different therapies: taxanes or hormone treatment. Until this day there are no comparative studies between the two and the decision on which treatment to use is done empirically and based on the patient's preferences.
› Verified 5 days ago
| Entity Name | Virginia Oncology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417929639 PECOS PAC ID: 2769395797 Enrollment ID: O20031106000522 |
News Archive
Scientists at Northwestern University report a surprising discovery that offers a possible new route for the treatment of neurodegenerative diseases. In a study of the transparent roundworm C. elegans, they found that a genetic switch in master neurons inhibits the proper functioning of protective cell stress responses, leading to the accumulation of misfolded and damaged proteins.
A new study at the Hebrew University of Jerusalem has found that Ethiopian women who immigrated to Israel gained significant amounts of weight, and some became obese, after integrating local foods into their diet and eating fewer traditional dishes.
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
The Bay Area Lyme Foundation today announced the first annual Bay Area Lyme Foundation 'Emerging Leader Award' and a $100,000 grant which will be given to a promising scientist who embodies the future of leadership in Lyme disease research.
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated with two different therapies: taxanes or hormone treatment. Until this day there are no comparative studies between the two and the decision on which treatment to use is done empirically and based on the patient's preferences.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stacey J Rogers, MD 5900 Lake Wright Dr, Suite 300, Norfolk, VA 23502-1871 Ph: (757) 213-5700 | Stacey J Rogers, MD 725 Volvo Pkwy, Suite 200, Chesapeake, VA 23320-1602 Ph: (757) 549-4403 |
News Archive
Scientists at Northwestern University report a surprising discovery that offers a possible new route for the treatment of neurodegenerative diseases. In a study of the transparent roundworm C. elegans, they found that a genetic switch in master neurons inhibits the proper functioning of protective cell stress responses, leading to the accumulation of misfolded and damaged proteins.
A new study at the Hebrew University of Jerusalem has found that Ethiopian women who immigrated to Israel gained significant amounts of weight, and some became obese, after integrating local foods into their diet and eating fewer traditional dishes.
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
The Bay Area Lyme Foundation today announced the first annual Bay Area Lyme Foundation 'Emerging Leader Award' and a $100,000 grant which will be given to a promising scientist who embodies the future of leadership in Lyme disease research.
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated with two different therapies: taxanes or hormone treatment. Until this day there are no comparative studies between the two and the decision on which treatment to use is done empirically and based on the patient's preferences.
› Verified 5 days ago
Mrs. Rachel D Lee, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3802 Poplar Hill Rd, Suite C, Chesapeake, VA 23321 Phone: 757-673-8383 Fax: 757-483-9350 | |
Pamela B Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3806 Poplar Hill Rd Ste C, Chesapeake, VA 23321 Phone: 757-483-4600 Fax: 757-484-2323 | |
Dr. Christian Manuel Perez, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 300 Medical Pkwy Ste 200, Chesapeake, VA 23320 Phone: 757-977-8500 Fax: 757-451-9694 | |
Craig H Ruetzel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 824 Greenbrier Pkwy, Suite 100, Chesapeake, VA 23320 Phone: 757-410-7390 Fax: 757-410-7395 | |
Peter J Kemp, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 300 Medical Pkwy, Suite 300, Chesapeake, VA 23320 Phone: 757-548-3880 Fax: 757-548-3373 | |
Angela Ferebee, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 713 Volvo Pkwy, Ste 200, Chesapeake, VA 23320 Phone: 757-547-4500 Fax: 757-547-4502 | |
Michael P Grimes, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 111 Medical Pkwy, Suite 202, Chesapeake, VA 23320 Phone: 757-436-2424 Fax: 757-436-7012 |